RARE DISEASE DAY 2025 The Neurenati Team is dedicated to develop a novel therapy for newborns affected by Hirschsprung disease (HD). NEU-001 is a combination therapy, composed of a neurotrophic growth factor, with strong intent of regenerating enteric nervous system in HD newborns.
